
This study demonstrates a novel approach using Adapter CAR (AdCAR) T cells to detect soluble latent TGF-β within the TME of a pancreatic tumour model. We show that AdCARs, combined with the respective adapter, can be used to sense soluble tumour-derived latent TGF-β in vitro and in vivo. Sensing the soluble antigen-induced cellular activation and effector cytokine production in AdCAR T cells. Moreover, we evaluated AdCAR T cells for the combined targeting of soluble latent TGF-β and tumour cell killing by targeting CD66c as TAA in vivo. The study broadens the spectrum of targetable moieties for AdCAR T cells by soluble latent TGF-β.
Like
Save
Share